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Purpose: To conduct a systematic literature review of the epidemiological and economic burden of surgical site infection 
(SSI) in Korea. Methods: A search of the EMBASE, Medline and KoreaMed databases for English and Korean language pub-
lications was conducted. Searches for epidemiological and economic studies were conducted separately and limited to 1995 
to 2010 to ensure the pertinence of the data. Results: Twenty-six studies were included. The overall incidence of SSI in Korea 
was 2.0 to 9.7%. The National Nosocomial Infections Surveillance risk index was positively correlated with the risk of devel-
oping an SSI. Specific risk factors for SSI, identified through multivariate analyses included; diabetes, antibiotic prophylaxis 
and wound classification. SSIs were associated with increased hospitalisation cost, with each episode of SSI estimated to cost 
about an additional ￦2,000,000. A substantial portion of the increased cost was attributed to hospital room costs and the 
need for additional medication. Studies also found that post-operative stays for patients with SSIs were 5 to 20 days longer, 
while two studies reported that following cardiac surgery, patients with SSIs spent an additional 5 to 11 days in the intensive 
care unit, compared to patients without SSIs. Conclusion: Data from the included studies demonstrate that SSI represents a 
significant clinical and economic burden in Korea. Consequently, the identification of high-risk patient populations and the 
development of strategies aimed at reducing SSI may lead to cost-savings for the healthcare system. 
Key Words: Surgical site infection, Epidemiology, Cost
INTRODUCTION
A surgical site infection (SSI) is a type of hospital-
acquired infection that arises following surgery and is spe-
cifically related to the surgical site. Patients who develop 
an SSI are more likely to have an extended hospital stay, 
which results in additional healthcare costs. Indirect costs, 
such as productivity, further add to the burden of SSI. 
The aim of this review is to summarise recent evidence 
pertaining to the clinical and economic burden of SSI in 
Korea. This systematic review will follow the general for-
mat of the publication by Leaper et al. [1] which describes 
the epidemiological and economic burden of SSI in 
Europe.  Kil Yeon Lee, et al.
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Table 1. Search strategy
Database/date searched Hits
Epidemiological search 
EMBASE/31 Mar 2010
1. (infection OR infections) NEAR/4 (surgical OR surgery OR wound OR nosocomial OR hospital OR ‘post operative’  152,064
OR post-operative OR ‘post discharge’ OR postdischarge OR icu OR ‘intensive care’)
2. ‘Incidence’/exp OR incidence OR ‘prevalence’/exp OR prevalence OR ‘epidemiology’/exp OR epidemiology OR  3,531,081
epidemiological OR surveillance OR rate
3. ‘Korea’/exp OR Korea OR Korean 159,915
4. #1 AND #2 AND #3 AND [1995-2010]/py 485
KoreaMed/1 May 2010
"post-operative infection" [ALL] OR "post-operative infection" [ALL] OR "post-surgical infection" [ALL] OR "postsurgical  744
   infection" [ALL] OR "surgical site infection" [ALL] OR "wound infection" [ALL] OR "nosocomial infection" [ALL] OR 
   "hospital acquired infection" [ALL] OR "healthcare associated infection" [ALL] OR "post-discharge infection" [ALL] OR 
   "postdischarge infection"
Economic/costing search
EMBASE/31 Mar 2010
1. (infection OR infections) NEAR/4 (surgical OR surgery OR wound OR nosocomial OR hospital OR 'post operative' OR  14
post-operative OR 'post discharge' OR icu OR 'intensive care') AND ('Korea'/exp OR Korea OR Korean) AND [1995-2010]
/py AND ('cost effectiveness analysis'/exp OR 'cost effectiveness analysis' OR 'economic evaluation'/exp OR 'economic 
evaluation' OR 'health economics'/exp OR 'health economics' OR 'cost minimization analysis'/exp OR 'cost minimization 
analysis' OR 'cost minimisation analysis' OR 'cost utility analysis'/exp OR 'cost utility analysis' OR 'quality adjusted life 
year'/exp OR 'quality adjusted life year' OR 'qaly'/exp OR 'qaly' OR 'life year saved')
Total number of unique citations 1,206
METHODS
Literature search
In order to identify relevant epidemiological and eco-
nomic data for this review, a systematic search of the liter-
ature was undertaken. A search of Embase (which in-
cludes the EMBASE and Medline databases) and a Korean 
medical journal database (KoreaMed) was conducted. 
Separate searches were conducted to identify epidemio-
logical and economic data. The search was limited to the 
last 15 years (1995 to 2010) to ensure the relevance of these 
data. The search strategy and results are presented in 
Table 1.
Identification of studies
There were 1,206 unique citations identified from the 
literature search. The titles/abstracts of all citations were 
reviewed to identify publications most relevant to this sys-
tematic review. The following exclusion criteria were ap-
plied to determine eligibility: 
1. Does not describe the rate, incidence, prevalence, bur  
den or cost of SSI.
2. Describes the effect of an intervention to reduce SSI.
3. Not conducted in Korea. 
4. Not conducted in a hospital setting.
5. Includes ＜90 patients/procedures.
Following application of the exclusion criteria to the ti-
tles/abstracts, 32 publications were retrieved for full text 
review. Following detailed assessment of these pub-
lications, a further six were excluded leaving 26 studies. 
Data extraction and analysis
SSI data from the 26 included studies were compiled in-
to data extraction tables. The overall incidence of SSI was 
recorded, as well as the incidence of SSI by surgical proce-
dure, wound classification and National Nosocomial 
Infections Surveillance (NNIS) risk score. Wound classi-
fications were based on definitions by the Centre for 
Disease Control (CDC). SSIs were classified according to 
the location in which they occurred: 1) superficial (i.e., skin 
and subcutaneous tissue); 2) deep (i.e., fascia, muscle); and 
3) organ / space. The NNIS categorizes patients according 
to their likelihood of developing an SSI. The NNIS system 
risk index comprises three components: 1) the AmericanEpidemiology and cost of surgical site infection
thesurgery.or.kr 297
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Table 3. Overall incidence of surgical site infection
No. of hospitals
Source Surgical procedure  Surveillance period Incidence
 surveyed
Ahn and Sohng [3] Any inpatient surgical procedure 1 30 days post-operation 51/527 (9.7%)
Lee et al. [19] All surgical procedures
a) 1 30 days post-operation 15/761 (2.0%)
Lee et al. [5] All surgical procedures
b) 1 30 days post-operation  33/1239 (2.7%)
  27 (pre-discharge)
    6 (post-discharge)
Park et al. [6] All procedures in surgery department 1 30 day post-operation 52/1007 (5.2%)
Sakong et al. [7] Five surgical procedures
c) 20 30 days to 1 year, unless  86/2924 (2.9%)
 lost to follow-up
a)Includes surgery of the colon, rectum, small bowel, hepato-biliary-pancreas, stomach and appendix. 
b)Includes orthopedic surgery, plastic 
surgery, general surgery, neurosurgery, chest surgery, obstetrics and gynecology, otolaryngology and ophthalmology. 
c)Includes cardiac, 
colon and gastric surgery, hysterectomy, hip/knee replacement surgery.
Society of Anaesthesiologists (ASA) score; 2) wound clas-
sification; and 3) the duration of surgery. Based on these 
factors, patients are assigned an NNIS risk score of 0, 1, 2 or 
3. The NNIS risk index is scored as follows: 1) an ASA 
score of 3 to 5 is allocated 1 point; 2) wound sites classified 
as contaminated or dirty are allocated 1 point; and 3) sur-
geries exceeding specified time cut-off points are allocated 
1 point. Risk factors for SSIs were also recorded, along 
with common pathogens associated with SSI. To evaluate 
the economic impact of SSI, SSI costs and extended hospi-
tal stay associated with SSI were summarised.
RESULTS
Characteristics of the included studies
A summary of the characteristics of included studies is 
presented in Table 2. The majority of the studies were ret-
rospective cohort studies investigating SSI or wound in-
fection following a range of hospital surgical procedures. 
There was significant variation in the size of the pop-
ulations investigated, with the number of patients in-
cluded ranging from 94 to 85,547. There were also differ-
ences in the surveillance period, which is likely to influ-
ence the opportunity to detect a SSI. SSIs were most com-
monly defined and classified using the CDC criteria. 
Prevalence of SSI in Korea
None of the studies included in this systematic review 
reported the prevalence of SSI in Korea. However, the 
multicentre study by Kim et al. [2], involving 15 hospitals, 
reported that the prevalence of nosocomial infection was 
3.7% in 2000, with SSIs accounting for 17.2% of all nosoco-
mial infections.
Incidence of SSI in Korea
As shown in Table 3, five included studies reported the 
overall incidence rate of SSIs [3-7]. Each study followed up 
patients who had undergone a variety of different surgical 
procedures. Four of the studies examined the incidence of 
SSI at a single hospital [3-6] during a 30 day post-operative 
observation period, while one study examined the in-
cidence of SSI across 20 hospitals during a one year 
post-operative follow-up period (Sakong et al. [7]). The in-
cidence of SSI ranged from 2.0 to 9.7% across the five in-
cluded studies.
Incidence by surgical procedure
As shown in Table 4, the incidence of SSI varied by sur-
gical procedure. To facilitate comparison, groups were 
divided into four broad categories, namely, cardiothoracic 
surgery, orthopaedic surgery, gastrointestinal surgery, 
and other surgical procedures. 
 There were seven studies that reported SSI following 
cardiothoracic surgery [8-13]. Surgical procedures inves-
tigated included open-heart surgery, sternotomy, nuss 
procedure, off-pump coronary artery bypass, thor-
acotomy for pulmonary aspergilloma and non-specific Kil Yeon Lee, et al.
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Table 4. Incidence of surgical site infection by surgical procedure
Source Surgical procedure Surveillance period Incidence (%)
Cardiothoracic surgery
Chang et al. [8] Open-heart surgery NS   12/123 (9.8)
Chang et al. [9] Sternotomy NS   15/157 (9.6)
Chung et al. [10] Nuss procedure NS   14/630 (2.2)
Song et al. [11] OPCAB Pre-discharge only     4/100 (4.0)
Park and Jheon [12] Thoracotomy for pulmonary Over 1 month post-operation     4/110 (3.6)
  aspergilloma
Sakong et al. [7] Cardiac surgery 30 days to 1 year, unless lost to follow-up     9/304 (3.0)
Choi et al. [13] Cardiovascular surgery 30 days post-operation   10/222 (4.5)
    8 (pre-discharge)
    2 (post-discharge)
Orthopaedic surgery
Choi et al. [14] Hip joint replacement surgery 1 month post-operation     3/227 (1.3)
Knee joint replacement surgery 1 month post-operation     3/209 (1.4)
Kim et al. [15] Hip prosthesis 1 year post-operation     6/342 (1.8)
Knee prosthesis 1 year post-operation     5/453 (1.1)
Sakong et al. [7] Hip or knee replacement 30 days to 1 year, unless lost to follow-up   15/597 (2.5)
Gastrointestinal tract surgery
Kim et al. [16] Biliary surgery NS     5/109 (4.8 )
Lee et al. [17] Gastrectomy in cirrhotic patients NS     10/94 (10.6)
Lee et al. [18] Endoscopic gastrostomy 2 weeks post-operation   19/134 (14.2)
Lee et al. [19] Endoscopic gastrostomy Mean of 26 days (range, 7 to 63 days)   37/116 (31.9)
Hong et al. [20] Bowel surgery in Crohn’s disease At least 1 month post-operation     6/160 (3.8)
Jeong et al. [21] Abdominal surgery 30 days post-operation   17/347 (4.9)
Kim et al. [15] Gastrectomy 30 days post-operation   22/499 (4.4)
Kim et al. [22] Peptic ulcer surgery 30 days post-operation   20/112 (17.9)
Lee et al. [19] Colon and rectum surgery 30 days post-operation     7/113 (6.2)
Hepato-biliary-pancreas 30 days post-operation     3/128 (2.3)
Appendix surgery 30 days post-operation     3/193 (1.6)
Park et al. [23] Laparoscopic gastrectomy 30 days post-operation   21/300 (7.0)
Sakong et al. [7] Colon surgery 30 days to 1 year, unless lost to follow-up   18/537 (3.4)
Gastric surgery 30 days to 1 year, unless lost to follow-up   29/589 (4.9)
Other surgical procedures
Kim et al. [24] Craniotomy 30 days post-operation 31/1020 (3.0)
Lee et al. [25] Limb salvage surgery in 1 year post-operation   41/371 (11.1)
  osteosarcoma patients
Sakong et al. [7] Hysterectomy 30 days to 1 year, unless lost to follow-up   15/897 (1.7)
NS, not stated; OPCAB, off-pump coronary artery bypass.
cardiac and cardiovascular surgery. The incidence of SSI 
ranged from 2.2 to 9.8%, with the highest incidence of SSI 
occurring in patients who had undergone open-heart sur-
gery [8] and the lowest incidence in those undergoing the 
nuss procedure [10]. Choi et al. [13] reported an incidence 
of SSI of 4.5% following cardiovascular surgery, of which, 
80% (8/10) occurred pre-discharge and 20% (2/10) 
post-discharge from hospital. 
The three included orthopaedic studies examined knee 
or hip replacement surgery with patients monitored for 
up to one year post-operation (Table 4). Overall, the in-
cidence of SSI was lower for patients undergoing ortho-
paedic surgery compared to those undergoing car-
diothoracic surgery. The incidence of SSI ranged from 1.1 
to 2.5%, with low variation between surgery types and du-
ration of follow-up [7,14,15]. 
The majority of the included studies in this systematic 
review examined SSI following gastrointestinal tract sur-
gery [4,7,15-23]. Overall, the incidence of SSIs was gen-
erally higher and the range of rates was larger for patients Epidemiology and cost of surgical site infection
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Table 5. Classification of surgical site infections
Surgical No. of SSI Source  procedure  cases
Classification of SSI
Organ/ Superficial Deep  space
Kim et al. Craniotomy 31 12.9% 6.5% 80.6%
  [24]
Kim et al. Hip 6 33.3% 50.0% 16.7%
  [15]   arthroplasty
 Knee 5 20.0% 40.0% 40.0%
  arthroplasty
 Gastrectomy 22 23.0% 9.0% 68.0%
Park et al. General 26 53.8% 46.2% 0.0%
  [6]   surgery
SSI, surgical site infection.
Table 6. Incidence of surgical site infection by wound classification
Source Procedure Surveillance period
Wound classification
Clean Clean-contaminated Contaminated Dirty
Ahn and Sohng [3] Any inpatient surgery 30 days post-operation 5.7% (10/167) 8.5% (19/215)  3.5% (2/56) 29.4% (20/48)
Choi et al. [13] Cardiovascular surgery 30 days post-operation 3.7% (8/216)    0% (0/0) 25% (1/4)    50% (1/2)
Jeong et al. [21] Abdominal surgery 30 days post-operation 1.6% (1/63) 5.2% (12/233)  6.8% (3/43) 12.5% (1/8)
Lee et al. [19] All surgical procedures 30 days post-operation    0% (0/227) 1.4% (2/138)  1.8% (6/341) 12.7% (7/55)
Lee et al. [5] All surgical procedures 30 days post-operation  2.6% (15/585) 1.3% (7/579)  6.1% (2/33) 12.5% (9/72)
Table 7. Incidence of surgical site infections by NNIS risk score
  Overall
Source Procedure Surveillance
incidence
NNIS risk score
01 2 3
Choi et al. [14] Hip joint replacement 1 month post-operation 1.32%   1.2% (2/166) 1.64% (1/61)          -        -
Knee joint replacement 1 month post-operation 1.44% 0.64% (1/156) 3.85% (2/52)    0% (0/1)        -
Choi et al. [13] Cardiovascular surgery 30 days post-operation 4.5%      0% (0/3)   3.1% (4/129) 4.6% (4/87) 66.7% (2/3)
Kim et al. [15] Hip prosthesis 1 year post-operation 1.75% 0.98% (2/205) 3.31% (4/121)    0% (0/16)
Knee prosthesis 1 year post-operation 1.1% 0.93% (3/323) 1.65% (2/121)    0% (0/9)
Gastrectomy 30 days post-operation 4.41% 5.29% (12/227) 6.11% (8/131) 10.53% (2/19)
Kim et al. [24] Craniotomy 30 days post-operation 3.0%   3.1% (14/457)   3.3% (15/454) 1.8% (2/109)        -
NNIS, National Nosocomial Infections Surveillance; NS, not stated. 
undergoing gastrointestinal tract surgery compared with 
other surgery types. The lowest rate of SSI was reported by 
Lee et al. [4] for patients undergoing appendix surgery 
(1.6% after 30 days follow-up). In contrast, Lee et al. [19] re-
ported that 31.9% of patients undergoing endoscopic gas-
trostomy experienced a SSI up to 2 months after surgery. 
Although the range of SSI rates was larger than rates from 
other surgery types, the majority of studies still reported 
SSI rates less than 7 .
Among the included studies investigating SSIs follow-
ing other surgical procedures, Kim et al. [24], Lee et al. [25] 
and Sakong et al. [7] examined craniotomy, limb salvage 
surgery in osteosarcoma patients and hysterectomy, 
respectively. The incidence of SSI up to one year following 
surgery was 3.0%, 11.1% and 1.7%, respectively.
Classification of surgical site infection
As shown in Table 5, three studies reported information 
on the classification of SSI [6,15,24]. In patients under-
going general surgery, the majority of SSIs occurred in su-
perficial tissue (53.8%) [6]. In contrast, organ/space SSIs 
were most frequent following craniotomy and gas-
trectomy [15,24]. The incidence of superficial, deep and or-
gan/space SSI appeared to be similar among patients un-
dergoing hip and knee replacement surgery. However, 
due to the small number of SSI cases observed for these 
surgeries, N = 6 and 5, respectively, the results should be 
interpreted with caution.
Incidence by wound classification
The incidence of SSI by wound classification is shown in Kil Yeon Lee, et al.
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Table 8. Risk factors for surgical site infections
Risk Reference Surgical Observation Risk  estimate Source  Analysis  type P-value variable variable   procedure  period (95% CI)
Patient-associated risk factors
 Kim et al. [26] 48 hr mean blood  48 hr mean blood  Lumbar spine            NS Multivariate OR ＞1 ＜0.05
   glucose ＞200   glucose ≤200   surgery
   mg/dL    mg/dL
 Lee et al. [19] Type 2 diabetes No diabetes Endoscopic Mean of 26 days  Multivariate OR 5.21 (1.94, 14.0)  0.001
  gastrostomy   (range, 7 to 63
  days)
 Lee et al. [18] Type 2 diabetes No diabetes Endoscopic 2 weeks  Multivariate OR 3.80  0.035
    gastrostomy   post-operation
 Jeong et al. [21] Co-morbidities No co-morbidities Abdominal 30 days  Multivariate OR 5.40 (1.48, 19.7)  0.011
     present 
a)   surgery   post-operation
 Park  et al. [23] Co-morbidities No co-morbidities Laparoscopic 30 days  Multivariate OR 2.38  0.018
     present 
b)   gastrectomy   post-operation
 Kim et al. [24] CSF leaks No CSF leaks Craniotomy 30 days  Multivariate OR 4.86 (4.54, 32.42)   NS
     post-operation
GCS score ≤  8G C S   ＞ 8 Craniotomy 30 days  Multivariate OR 2.35 (1.07, 5.18)   NS
  post-operation
 Lee et al. [19] Leukocytosis No leukocytosis Endoscopic Mean of 26 days Multivariate OR 3.15 (1.19, 8.35)  0.021
    gastrostomy   (range, 7 to 63 
  days)
 Lee et al. [5] Dirty infected Clean wound All surgical 30 days  Multivariate OR 6.51 (2.13, 19.90)  0.001
    wound   procedures   post-operation
Procedure-associated risk factors
 Kim et al. [27] Laparoscopy Open surgery Appendectomy            NS Meta-analysisOR 0.33 (0.20, 0.55) ＜0.05
    of 8 studies,
  fixed effects
  model
 Lee et al. [19] No antibiotic Antibiotic Endoscopic Mean of 26 days Multivariate OR 3.67 (1.01, 13.4)  0.048
     prophylaxis   prophylaxis   gastrostomy   (range: 7-63 days)
 Sakong  Antibiotics given  Antibiotics given 5 major 30 days to 1 year, Multivariate RR 8.20 (4.81, 13.99) ＜0.05
   et al. [7]   ＞1 hr    ＜1 hr    surgeries
c)   unless lost to
  pre-operation   pre-operation   follow-up
 Lee  et al. [5] Pre-operative stay (risk per additional day)All surgical 30 days  Multivariate OR 1.038 (1.004, 1.073)  0.029
  procedures   post-operation
No. of operations/patient All surgical 30 days  Multivariate OR 3.27 (1.48, 7.27)  0.004
  procedures   post-operation
Duration of operation All surgical 30 days  Multivariate OR 1.007 (1.004, 1.009)＜0.001
     (risk per hour increase)   procedures   post-operation
CI, confidence interval; CSF, cerebrospinal fluid; GCS, Glasgow Coma Scale; NS, not stated; OR, odds ratio.
a)Includes hypertension, cancer and diabetes. 
b)Includes diabetes, hypertension, heart/liver/renal disease. 
c)Includes cardiac, colon and gastric
surgery, hysterectomy, hip/knee replacement surgery.
Table 6. A study by Ahn and Sohng [3] examined various 
inpatient surgeries and observed that 5.7% of patients 
with a clean wound had an SSI within 30 days post- 
operation. In comparison, the incidence of SSI was 29.4% 
among patients with wounds classified as dirty. Similar 
trends were observed in the other included studies, where 
the incidence of SSIs increased as wound conditions 
worsened. 
Incidence by NNIS risk score
Four studies included in this review compared the in-
cidence of SSI between NNIS risk categories (Table 7). 
Overall, the results showed that the higher the NNIS risk 
score, the greater the risk of SSI. In a study by Choi et al. Epidemiology and cost of surgical site infection
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[14], the incidence of SSI in those with a NNIS risk score of 
0 and 1 following hip replacement was 1.2% and 1.6%, 
respectively. In the same study, the incidence of SSI for 
NNIS risk score 0 and 1 following knee replacement was 
0.6% and 3.9%, respectively. A similar trend was observed 
in the studies by Kim et al. [15] and Kim et al. [24] that ex-
amined SSI following a variety of surgery types. 
Risk factors associated with SSI in Korea
The risk factors for SSI are shown in Table 8. Nine stud-
ies included in this systematic review examined the asso-
ciation of specific risk factors with the incidence of SSI. 
Only factors which showed significant association with 
SSI through multivariate analysis were included, as uni-
variate analysis does not take into account the possible 
confounding effects of other variables.
Patient-associated factors
Diabetes was identified as a patient-associated risk fac-
tor in three studies. Kim et al. [26] reported that following 
lumbar spine surgery, patients with a mean blood glucose 
level greater than 200 mg/dL at 48 hours post-surgery had 
a significantly higher incidence of SSI (P ＜  0.05, effect esti-
mate not reported). Lee et al. [19] and Lee et al. [18] exam-
ined patients undergoing endoscopic gastrostomy. Type 2 
diabetes was significantly associated with an increased 
risk of SSI in both studies (odds ratio [OR], 5.21; P = 0.001 
and OR, 6.51; P = 0.001, respectively). Similarly, Jeong et al. 
[21] and Park et al. [23] both reported that co-morbidities 
(e.g., diabetes, hypertension, cancer) significantly in-
creased the risk of SSI in patients undergoing abdominal 
surgery (OR, 5.4; P = 0.011) and laparoscopic gastrectomy 
(OR, 2.38; P = 0.018). 
 Lee et al. [5] showed that surgical patients with dirty in-
fected wounds were at increased risk of developing SSIs, 
compared to surgical patients with clean wounds (OR, 
6.51; P = 0.001). The incidence of SSI was associated with 
cerebrospinal fluid leaks (OR, 4.86; P ＜ 0.05) and a 
Glasgow Coma score of ＞8 (OR, 6.51; P ＜  0.05) in patients 
undergoing craniotomy [24], while leukocytosis increased 
the risk of SSIs among patients undergoing endoscopic 
gastrostomy (OR, 3.15; P = 0.021), Lee et al. [19]. 
Procedure-associated factors
Kim et al. [27] conducted a meta-analysis of eight stud-
ies and found that the use of laparoscopy instead of open 
surgery for appendectomies reduced the risk of SSIs (OR, 
0.33; 95% confidence interval, 0.20 to 0.55). Lee et al. [19] 
and Sakong et al. [7] showed that the absence of antibiotic 
prophylaxis and administration of antibiotics ＞1 hour be-
fore surgery significantly increased the risk of SSI (OR, 
3.67; P = 0.048 and OR, 8.2; P ＜  0.05, respectively). A study 
by Lee et al. [5] identified several other procedure-asso-
ciated risk factors that increased the risk of SSI. These in-
cluded length of pre-operative stay (risk per additional 
day: OR, 1.038; P = 0.029), number of operations performed 
on the patient (risk per additional operation: OR, 3.27; P = 
0.004) and duration of operation (risk per hour increase: 
OR, 1.007; P ＜  0.001).
SSI associated mortality
Only one study identified in this review examined the 
incidence of SSI-associated mortality. A study by Lee et al. 
[25] found no significant differences in the 5-year survival 
between patients with deep wound infections compared 
to patients with no infection following limb salvage sur-
gery for osteosarcoma (88.9% vs. 82%, P = 0.49). 
Pathogens associated with SSI in Korea
Ten of the included studies, comprising a range of surgi-
cal procedures, reported information on the pathogens 
present at the SSI (Table 9). The pathogens most commonly 
identified were Staphylococcus aureus (MRSA and MSSA), 
Enterobacter spp., Enterococcus spp. and Klebsiella pneu-
monia. The relative proportions of methicillin-resistant 
and methicillin-sensitive S. aureus varied between studies, 
but MRSA tended to be more common.
Economic burden data
Extended hospital stay
A substantial portion of the economic cost of SSI is 
attributable to increased length of hospital stay. As shown 
in Table 10, this review identified four studies that 
examined the association between hospital stay and SSI. 
Ahn and Shong [3] reported that following inpatient surgery, Kil Yeon Lee, et al.
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patients with SSIs experienced a significantly longer stay 
in hospital (31.8 days vs. 11.5 days, P ＜  0.001). Similarly, 
Park et al. [6] reported significantly longer post-operative 
stays in patients with SSIs (14.15 days vs. 8.96 days, P = 
0.019). Chang et al. [8,9] reported that intensive care unit 
stay was longer in patients with SSI following sternotomy 
and open heart surgery, respectively. 
Cost of surgical site infections
Hospitalisation cost associated with SSI for patients un-
dergoing general surgery at Severance Hospital in Seoul 
was reported in a publication by Park et al. [6] (Table 11). 
The cost of hospitalisation was, on average, ￦2,153,964 
higher in patients with SSI, compared to patients with no 
SSI (P = 0.045). A substantial portion of the increased cost 
was due to hospital room costs and the need for additional 
medication. The authors noted that the costs are likely an 
underestimation of the actual economic cost of SSI, as only 
hospital expenditure data were considered. In a study by 
Ahn and Shong [3], the cost of antibiotics in patients un-
dergoing inpatient surgical procedures was ￦735,155 
(SD, 526,336) among those who developed an SSI, com-
pared to ￦174,087 (SD, 171,326) for patients without SSI. 
The increased cost of antibiotics among patients with SSI 
was found to be statistically significant (￦561,068 P ＜ 
0.001).
DISCUSSION
The overall incidence of SSI in Korea ranged between 
2.0 to 9.7%. The wide range may be due to differences in 
the types of surgical procedures examined, or the levels of 
risk factors in the patients included in the studies. In par-
ticular, surgery involving the gastrointestinal system was 
generally associated with higher rates of SSI. Patient-asso-
ciated risk factors such as diabetes, wound conditions and 
patient health were associated with a significantly greater 
risk of SSI. Similarly, procedure-associated factors such as 
antibiotic treatment and surgery duration were also found 
to influence the risk of SSI.
 There are a number of limitations with this review. The 
inclusion of studies was assessed based on the information 
T
a
b
l
e
 
9
.
C
o
m
m
o
n
 
p
a
t
h
o
g
e
n
s
 
a
s
s
o
c
i
a
t
e
d
 
w
i
t
h
 
s
u
r
g
i
c
a
l
 
s
i
t
e
 
i
n
f
e
c
t
i
o
n
N
o
.
 
o
f
 
S
u
r
g
i
c
a
l
 
S
o
u
r
c
e
c
u
l
t
u
r
e
s
p
r
o
c
e
d
u
r
e
t
e
s
t
e
d
F
r
e
q
u
e
n
c
y
 
o
f
 
p
a
t
h
o
g
e
n
s
 
c
a
u
s
i
n
g
 
S
S
I
 
(
%
)
E
s
c
h
e
r
i
c
h
i
a
P
s
e
u
d
o
m
o
n
a
s
 
S
t
a
p
h
y
l
o
c
o
c
c
u
s
E
n
t
e
r
o
b
a
c
t
e
r
E
n
t
e
r
o
c
o
c
c
u
s
S
t
r
e
p
t
o
c
o
c
c
u
s
C
a
n
d
i
d
a
K
l
e
b
s
i
e
l
l
a
O
t
h
e
r
s
/
n
o
t
 
M
S
S
A
M
R
S
A
 
c
o
l
i
 
a
e
r
u
g
i
n
o
s
a
 
e
p
i
d
e
r
m
i
s
 
s
p
p
.
 
s
p
p
.
 
s
p
p
.
 
a
l
b
i
c
a
n
s
 
p
n
e
u
m
o
n
i
a
 
s
p
e
c
i
f
i
e
d
 
A
h
n
 
a
n
d
 
S
o
h
n
g
 
[
3
]
A
n
y
 
i
n
p
a
t
i
e
n
t
 
s
u
r
g
e
r
y
 
 
5
6
1
4
.
0
1
0
.
5
1
.
8
1
2
.
3
-
8
.
8
1
5
.
8
1
0
.
5
3
.
5
1
0
.
5
1
0
.
7
 
J
e
o
n
g
 
e
t
 
a
l
.
 
[
2
1
]
A
b
d
o
m
i
n
a
l
 
s
u
r
g
e
r
y
 
 
1
5
1
3
.
3
-
-
3
3
.
3
-
2
6
.
7
2
6
.
7
-
-
-
-
 
K
i
m
 
e
t
 
a
l
.
 
[
1
5
]
H
i
p
/
k
n
e
e
 
a
r
t
h
r
o
p
l
a
s
t
y
 
 
2
5
1
0
.
0
1
0
.
0
1
0
.
0
3
.
3
-
6
.
7
2
0
.
0
1
3
.
3
3
.
3
1
3
.
3
1
0
.
0
 
 
a
n
d
 
g
a
s
t
r
e
c
t
o
m
y
 
K
i
m
 
e
t
 
a
l
.
 
[
2
4
]
C
r
a
n
i
o
t
o
m
y
 
 
1
3
-
6
.
7
-
2
0
.
0
-
2
0
.
0
-
2
6
.
7
-
1
3
.
3
1
3
.
3
 
K
i
m
 
e
t
 
a
l
.
 
[
2
]
A
n
y
 
s
u
r
g
i
c
a
l
 
p
r
o
c
e
d
u
r
e
6
2
6
7
.
3
1
5
.
0
3
.
2
2
5
.
1
2
.
2
5
.
6
9
.
7
6
.
4
1
.
4
3
.
7
2
0
.
4
 
L
e
e
 
e
t
 
a
l
.
 
[
1
9
]
E
n
d
o
s
c
o
p
i
c
 
g
a
s
t
r
o
s
t
o
m
y
 
 
3
3
7
.
0
3
3
.
0
2
.
0
3
8
.
0
-
-
-
-
-
1
1
.
0
9
.
0
 
L
e
e
 
e
t
 
a
l
.
 
[
2
5
]
L
i
m
b
 
s
a
l
v
a
g
e
 
s
u
r
g
e
r
y
 
i
n
 
 
1
7
a
)
-
5
.
9
4
1
.
2
2
9
.
4
1
1
.
8
-
5
.
9
5
.
9
-
-
-
 
 
o
s
t
e
o
s
a
r
c
o
m
a
 
p
a
t
i
e
n
t
s
 
L
e
e
 
e
t
 
a
l
.
 
[
1
8
]
E
n
d
o
s
c
o
p
i
c
 
g
a
s
t
r
o
s
t
o
m
y
 
 
1
9
2
.
9
3
2
.
4
2
.
9
2
9
.
4
-
 
 
-
5
.
8
2
.
9
-
1
1
.
8
1
1
.
8
 
L
e
e
 
e
t
 
a
l
.
 
[
1
9
]
A
l
l
 
s
u
r
g
i
c
a
l
 
p
r
o
c
e
d
u
r
e
s
 
 
1
5
6
.
3
-
-
1
8
.
8
-
1
2
.
5
3
1
.
3
6
.
3
-
1
2
.
5
1
2
.
5
 
L
e
e
 
e
t
 
a
l
.
 
[
5
]
A
l
l
 
s
u
r
g
i
c
a
l
 
p
r
o
c
e
d
u
r
e
s
 
 
3
3
6
.
2
-
6
.
1
2
1
.
2
-
3
.
0
6
.
2
2
4
.
2
-
6
.
2
2
7
.
3
S
S
I
,
 
s
u
r
g
i
c
a
l
 
s
i
t
e
 
i
n
f
e
c
t
i
o
n
;
 
M
R
S
A
,
 
m
e
t
h
i
c
i
l
l
i
n
-
r
e
s
i
s
t
a
n
t
 
S
t
a
p
h
y
l
o
c
o
c
c
u
s
 
a
u
r
e
u
s
;
 
M
S
S
A
,
 
m
e
t
h
i
c
i
l
l
i
n
-
s
u
s
c
e
p
t
i
b
l
e
 
S
t
a
p
h
y
l
o
c
o
c
c
u
s
 
a
u
r
e
u
s
;
 
N
S
,
 
n
o
t
 
s
t
a
t
e
d
.
a
)
C
u
l
t
u
r
e
s
 
f
r
o
m
 
d
e
e
p
 
i
n
f
e
c
t
i
o
n
s
 
o
n
l
y
.Epidemiology and cost of surgical site infection
thesurgery.or.kr 305
Table 10. Extended hospital stay associated with surgical site infection
Source Surgical procedure Type of stay
Length of stay (days)
SSI No SSI Difference P-value
Ahn and Sohng [3] Any inpatient surgery Post-operative   31.8 (SD, 27.9) 11.5 (SD, 9.3) 20.3 ＜0.001
Park et al. [6] All surgical procedures Post-operative  14.15 (SD, 8.02) 8.96 (SD, 7.19) 5.19 0.019
Chang et al. [9]
a) Sternotomy ICU   10.8 (SD, 10.1)   5.0 (SD, 4.6) 5.8 0.005
Chang et al. [8] Open-heart surgery ICU    14.5 (SE, 26.2)   3.1 (SE, 3.3) 11.4 ＜0.001
ICU, intensive care unit; SD, standard deviation; SE, standard error; SSI, surgical site infection.
a)Comparing patients with mediastinitis to those with no infection.
Table 11. Hospitalisation cost associated with surgical site infection in Korea [6]
Source of cost
Mean cost (SD)
SSI (￦) No SSI (￦) Mean difference (￦)P - v a l u e
Doctor’s fee      29,341 (34,765)      21,098 (24,718) 8,243 0.423
Operation 1,168,336 (708,235)    929,193 (337,490) 239,143 0.141
Room 1,513,334 (2,056,657)    790,220 (641,009) 723,114 0.105
Meal    197,036 (137,904)    124,785 (107,639) 72,251 0.047
Anaesthesia    455,783 (287,738)    400,555 (181,873) 55,228 0.428
Blood    176,440 (406,090)      68,594 (60,688) 107,846 0.468
Radiology tests    339,684 (783,692)    274,341 (759,276) 65,343 0.768
Laboratory tests    384,940 (401,864)    204,059 (211,755) 180,881 0.055
Medication 1,227,428 (1,366,122)    669,282 (721,234) 558,146 0.082
Dressings and injections    330,340 (288,759)    172,778 (159,859) 157,562 0.023
Others      26,638 (115,021)      28,740 (119,676) -2,102 0.950
Total 6,316,895 (4,630,l866) 4,162,931 (2,266,829) 2,153,964 0.045
SD, standard deviation; SSI, surgical site infection. 
presented in the title and abstract. As such, studies that re-
ported the rates of SSI as a secondary outcome may not 
have been identified. However, expanding the search to 
include all publications assessing post-surgical outcomes 
in patients would have substantially increased the total 
number of publications identified in the literature search. 
This would have likely resulted in the identification of ad-
ditional publications, generally related to case series of 
specific surgical techniques. Case series often have small 
sample sizes and would have only served to provide in-
cidence rates of SSI over a broader range of surgeries than 
those reported here. 
 Differences in study designs made it difficult to com-
bine the data and obtain summary estimates of the in-
cidence of SSI. These include differences in follow-up du-
ration, method of data collection, and consideration for 
the use of antibiotics in the estimates. Most of the studies 
identified in this systematic review assessed SSI during 
the hospitalisation (pre-discharge) period, as well as dur-
ing the post-discharge period, typically for 30 days, ac-
cording to the CDC definition for post-operative infection. 
However, some studies only assessed SSI prior to dis-
charge [11], while others conducted follow-up over one 
year [25]. With a substantial portion of SSI often occurring 
after discharge from hospital, studies that do not conduct 
post-discharge surveillance are likely to underestimate 
the incidence of SSI. As shown in the studies by Lee et al. 
[5] and Choi et al. [13], approximately 20% of SSIs occurred 
post-discharge. The manner that data is collected (e.g., 
method of post-discharge surveillance) influences the ac-
curacy of the estimates, which in turn compromises in-
ter-study comparisons. For example, in the studies by Kim 
et al. [24] and Kim et al. [15], patients who did not return 
for outpatient checks after discharge were contacted by 
telephone by infection control nurses. In comparison, 
Jeong et al. [21] derived post-discharge information solely Kil Yeon Lee, et al.
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from the patients’ medical records. The use of antibiotic 
prophylaxis has been shown to be significantly associated 
with risk of SSI [7]. Consequently, studies that do not con-
sider or account for the use of antibiotic prophylaxis may 
result in biased estimates, making their comparison be-
tween studies inappropriate.
 SSIs represent a substantial economic burden, mainly 
attributable to the extended length of stay in hospital. In 
Korea, the incremental cost of an SSI is estimated at 
￦2,153,964 (approximately US$2,025) [6]. In comparison, 
the cost per case of SSI in Japan has been estimated at ap-
proximately US$1,600 in patients undergoing colorectal 
surgery [28], while in Australia, the cost per case of SSI is 
estimated at US$2,200 [29]. In addition, SSIs result in the 
loss of productivity in patients and carers. As reported by 
two studies in this review [5,13], a significant proportion 
(-20%) of SSIs was identified after discharge from hospital. 
Consequently, SSIs have the potential to further increase 
the burden on community healthcare services and the 
families of patients. 
 This review has shown that SSIs represent a significant 
clinical and economic burden in Korea. In particular, cer-
tain patient populations appear to be at increased risk of 
developing SSI, such as patients undergoing gastric sur-
gery or patients with dirty/contaminated wounds. Conse-
quently, strategies and interventions during surgery that 
reduce the incidence of SSIs would likely translate. For ex-
ample, recent clinical trials [30-32] have shown that the use 
of anti-bacterial coated sutures may reduce the incidence 
of SSIs by up to 40%. The dev elopment of such inter-
ventions would reduce patient morbidity associated with 
the development of SSIs, in turn, this could potentially 
translate into cost-savings for the healthcare system.
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